InMode(US:INMD) Prnewswireยท2025-01-08 12:00Core Viewpoint - InMode Ltd. anticipates releasing its financial results for Q4 and full year 2024 on February 6, 2025, with preliminary results indicating stronger-than-expected challenges in the aesthetics industry due to macroeconomic factors [2][7]. Financial Performance - Expected revenue for Q4 2024 is projected to be between $97.0 million and $97.5 million, while the full year 2024 revenue is estimated to be in the range of $394.0 million to $394.5 million [7]. - The non-GAAP gross margin for the full year 2024 is anticipated to be between 80% and 81% [7]. - Revenue for the full year 2025 is projected to be between $395 million and $405 million [7]. Company Overview - InMode is a global provider of innovative medical technologies, focusing on devices that utilize novel radiofrequency technology for various medical applications [8]. - The company aims to enhance surgical procedures and improve existing treatments through its minimally invasive RF technologies, offering a comprehensive product line across multiple medical fields [8].